Sale!

(Ebook PDF) The Peripheral T Cell Lymphomas 1st edition by Owen A O’Connor, Won Seog Kim, Pier Zinzani isbn 9781119671367 1119671361 full chapters

Name: (Ebook PDF) The Peripheral T Cell Lymphomas 1st edition by Owen A O'Connor, Won Seog Kim, Pier Zinzani isbn 9781119671367 1119671361 full chapters
SKU: EB-32194648
Availability: InStock

Original price was: $50.00.Current price is: $25.00.

The Peripheral T-Cell Lymphomas Owen A. O’Connor Digital Instant Download

Author(s): Owen A. O’Connor; Won Seog Kim; Pier L. Zinzani

ISBN(s): 9781119671367, 1119671361

File Details: PDF, 33.33 MB

Year: 2021

Language: English

SKU: EB-32194648 Category: Medicine Tag: Owen A. O'Connor; Won Seog Kim; Pier L. Zinzani

Description

(Ebook PDF) The Peripheral T Cell Lymphomas 1st edition by Owen A O’Connor, Won Seog Kim, Pier Zinzani -Ebook PDF Instant Download/Delivery:9781119671367, 1119671361

Instant download Full Chapter of after payment

Product details:

ISBN 10:1119671361

ISBN 13:9781119671367

Author: Owen A. O’Connor, Won Seog Kim, Pier L. Zinzani

The first text dedicated to peripheral T-cell lymphomas and their classification, diagnosis, and management Peripheral T-cell lymphomas (PTCL) are a diverse group of lymphoid malignancies that develop from mature T cells and natural killer (NK) cells. PTCL represents 10-15% of all cases of non-Hodgkin lymphoma in the US, and up to 20-25% of cases in South America, Asia, and other regions around the world. The role of different etiologic factors and the variation of geographic distribution makes PTCL one of the most difficult types of cancer to understand and treat. The first book of its kind, The Peripheral T-Cell Lymphomas presents a far-reaching survey of this complex and rare group of blood cancers. Featuring contributions from thought-leaders concerned with all aspects of PTCL, this authoritative text covers biology, epidemiology, classification, approved and emerging drugs, molecular genetics, and more. Detailed clinical chapters address diagnosis, prognosis, and treatment of each of the major PTCL subtypes identified in the 2018 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. This much-needed resource: Covers the biological basis, epidemiology, classification, and treatment of PTCL Discusses the future of the field, including global collaboration efforts and novel approaches to PCTL Explores the role of biologics in PTCL and autologous and allogeneic stem-cell transplantation Offers new insights on molecular pathogenesis, innovative therapeutics, and novel drug combinations Features contributions from the Chairs The T-Cell Lymphoma Forum: the world’s largest meeting focused on PTCL Reflecting the unique epidemiology and genetic diversity of the PTCL, The Peripheral T-Cell Lymphomas is an indispensable source of data, insight, and references for the medical community, particularly those working in oncology and hematology.

Part II: Epidemiology and Classification of the PTCL
5. Geographic Distribution of the Peripheral T‐cell Lymphomas
5.A. 2017 World Health Organization Classification of Mature T- and NK-cell Neoplasms
6. Classification of the Peripheral T‐cell Lymphomas
7. Molecular Classification of the Peripheral T‐cell Lymphomas

Part III: Discrete Clinical Subtypes of PTCL (Unique Epidemiology, Therapy, and Management)
8. Peripheral T‐cell Lymphoma Not Otherwise Specified
9. Angioimmunoblastic T‐cell Lymphoma
10. The Spectrum of Anaplastic Large‐cell Lymphoma
11. Human T‐cell Lymphotropic Virus Type 1 Positive Adult T‐cell Leukemia/Lymphoma
12. Natural Killer/T‐cell Lymphomas
13. T‐Prolymphocytic Leukemia
14. Large Granular Lymphocyte Leukemia
15. Gamma–Delta T‐cell Lymphomas
16. Enteropathy‐Associated and Monomorphic Epitheliotropic Intestinal T‐cell Lymphomas
17. Hepatosplenic T‐cell Lymphomas
18. Cutaneous T‐cell Lymphoma
19. Other Rare Subtypes of Peripheral T‐cell Lymphoma

Part IV: Treatment of the PTCL
20. Standard Front‐line Therapies
21. Approved Agents in the Relapsed or Refractory Setting, Excluding Brentuximab Vedotin
22. The Role of Autologous Stem‐cell Transplantation in Peripheral T‐cell Lymphomas
23. Allogeneic Stem‐cell Transplantation
24. Emerging Immunotherapy Approaches in Peripheral T‐cell Lymphomas
25. Emerging New Small Molecules in Peripheral T‐cell Lymphomas

Part V: Future Directions
26. The Value and Relevance of T‐cell Lymphoma Registries
27. Innovative Chemotherapy‐free Approaches for the Treatment of Peripheral T‐Cell Lymphoma
28. Global Collaborations

People also search:

how i treat the peripheral t cell lymphomas
peripheral t cell lymphomas from the bench to the clinic
what is peripheral t cell lymphoma
what causes peripheral t cell lymphoma
is peripheral t cell lymphoma curable